Skip to main content

Protalix Biotherapeutics (NY: PLX )

1.160 UNCHANGED
Official Closing Price Updated: 6:30 PM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
June 12, 2014
Form 8-K
Source: SEC/Edgar
May 29, 2014
Form 8-K
Source: SEC/Edgar
May 21, 2014
Form 8-K
Source: SEC/Edgar
February 11, 2014
Form SC 13G
Source: SEC/Edgar
February 11, 2014
Form SC 13G/A
Source: SEC/Edgar
February 11, 2014
Form SC 13G
Source: SEC/Edgar
January 27, 2014
Form 8-K
Source: SEC/Edgar
January 12, 2014
Form CT ORDER
Source: SEC/Edgar
November 28, 2013
Form 8-K
Source: SEC/Edgar
November 11, 2013
Form 8-K
Source: SEC/Edgar
October 14, 2013
Form ARS
Source: SEC/Edgar
September 30, 2013
Form DEF 14A
Source: SEC/Edgar
September 19, 2013
Form 8-K
Source: SEC/Edgar
September 10, 2013
Form 8-K
Source: SEC/Edgar
September 02, 2013
Form 8-K
Source: SEC/Edgar
June 19, 2013
Form 8-K
Source: SEC/Edgar
June 18, 2013
Form 8-K
Source: SEC/Edgar
June 11, 2013
Form 8-K
Source: SEC/Edgar
April 28, 2013
Form 8-K
Source: SEC/Edgar
April 01, 2013
Form 8-K
Source: SEC/Edgar
March 17, 2013
Form 8-K
Source: SEC/Edgar
March 06, 2013
Form 8-K
Source: SEC/Edgar
February 12, 2013
Form SC 13G/A
Source: SEC/Edgar
February 11, 2013
Form SC 13G/A
Source: SEC/Edgar
February 06, 2013
Form 8-K
Source: SEC/Edgar
February 04, 2013
Form 8-K
Source: SEC/Edgar
December 09, 2012
Form 8-K
Source: SEC/Edgar
December 05, 2012
Form 8-K
Source: SEC/Edgar
October 31, 2012
Form CT ORDER
Source: SEC/Edgar
October 15, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.